Testing a faster infection test to improve antibiotic use
Part of Infections clinical trials.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently hospitalized at the participating hospital in Elche.
- You are starting a strong antibiotic that needs special review.
- You or your representative can sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a quality improvement program to help ICUs use fewer antibiotics without compromising patient safety. It looks at how well the intervention works to reduce antimicrobial use in critically ill patients.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This study tests whether getting antibiotic resistance test results faster (within 6 hours) helps doctors choose the right antibiotic sooner for ICU patients with bloodstream infections caused by certain bacteria. Faster, accurate treatment may lead to better outcomes.
This trial aims to improve how antibiotics are chosen for patients with resistant bacterial infections in the blood. It uses faster diagnostic tests and expert advice to ensure the most effective treatment.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
This study compares different laboratory methods to find the exact germs causing your sepsis more quickly and accurately. Faster identification could mean better targeted treatment, potentially improving your recovery.
Hear when a new Antimicrobial Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.